Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine vs midazolam for preoperative anxiety in gynecological day surgery
ChiCTR2600120977Phase 4Not yet recruiting
- Sponsor
- Zhongshan People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in anxiety disorder (2 arms), sponsored by Zhongshan People's Hospital. Primary endpoint: Visual analog scale for anxiety (VAS-A). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2600120977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120977.